Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux

2015 ◽  
Vol 9 (3) ◽  
pp. 390-395 ◽  
Author(s):  
Pimjai Anthanont ◽  
Bela F. Asztalos ◽  
Eliana Polisecki ◽  
Benoy Zachariah ◽  
Ernst J. Schaefer
Author(s):  
Sana W. Sakr ◽  
David L. Williams ◽  
Genevieve W. Stoudt ◽  
Michael C. Phillips ◽  
George H. Rothblat

2011 ◽  
Vol 81 (6) ◽  
pp. 819-824 ◽  
Author(s):  
Hongyan Cui ◽  
Keiichiro Okuhira ◽  
Nobumichi Ohoka ◽  
Mikihiko Naito ◽  
Hiroyuki Kagechika ◽  
...  

2007 ◽  
Vol 402 (1) ◽  
pp. 117-124 ◽  
Author(s):  
Gunther Marsche ◽  
Sǎsa Frank ◽  
John G. Raynes ◽  
Karen F. Kozarsky ◽  
Wolfgang Sattler ◽  
...  

During the acute-phase reaction, SAA (serum amyloid A) replaces apoA-I (apolipoprotein A-I) as the major HDL (high-density lipoprotein)-associated apolipoprotein. A remarkable portion of SAA exists in a lipid-free/lipid-poor form and promotes ABCA1 (ATP-binding cassette transporter A1)-dependent cellular cholesterol efflux. In contrast with lipid-free apoA-I and apoE, lipid-free SAA was recently reported to mobilize SR-BI (scavenger receptor class B, type I)-dependent cellular cholesterol efflux [Van der Westhuyzen, Cai, de Beer and de Beer (2005) J. Biol. Chem. 280, 35890–35895]. This unique property could strongly affect cellular cholesterol mobilization during inflammation. However, in the present study, we show that overexpression of SR-BI in HEK-293 cells (human embryonic kidney cells) (devoid of ABCA1) failed to mobilize cholesterol to lipid-free or lipid-poor SAA. Only reconstituted vesicles containing phospholipids and SAA promoted SR-BI-mediated cholesterol efflux. Cholesterol efflux from HEK-293 and HEK-293[SR-BI] cells to lipid-free and lipid-poor SAA was minimal, while efficient efflux was observed from fibroblasts and CHO cells (Chinese-hamster ovary cells) both expressing functional ABCA1. Overexpression of SR-BI in CHO cells strongly attenuated cholesterol efflux to lipid-free SAA even in the presence of an SR-BI-blocking IgG. This implies that SR-BI attenuates ABCA1-mediated cholesterol efflux in a way that is not dependent on SR-BI-mediated re-uptake of cholesterol. The present in vitro experiments demonstrate that the lipidation status of SAA is a critical factor governing cholesterol acceptor properties of this amphipathic apolipoprotein. In addition, we demonstrate that SAA mediates cellular cholesterol efflux via the ABCA1 and/or SR-BI pathway in a similar way to apoA-I.


Sign in / Sign up

Export Citation Format

Share Document